A Smarter Approach to Hormone Optimization Peptide therapy represents a shift toward personalized, regenerative medicine
Semaglutide decreased spinal cord microglial and astrocyte activation and reduced pro-inflammatory cytokines (IL-1, IL-6, TNF-) and advanced glycation end products (AGEs) [86]
Introduction Among 369 diseases analyzed across 204 countries, headache disorders ranked 14th in disability-adjusted life years (DALYs) for the general population and were positioned as the second leading cause of DALYs in females aged 1549 years (1)
A key aspect of these relationships is both what they can provide us in terms of access and exposure but also what we provide in terms of education, new customers and new use cases to seek out solutions at these stores. Online supplement retailers also betting big on GLP-1
Observing your progress helps determine when to conclude treatment
SGLT2 inhibition: a new era in renoprotective medicine